Role of serum amylase and salivary cytokines in oral complications during chemoradiotherapy.
Kenta KawaharaAkimitsu HirakiHidetaka AritaHisashi TakeshitaAkiyuki HirosueYuichiro MatsuokaJunki SakataYuko ObayashiHikaru NakashimaMayumi HirayamaMasashi NagataRyoji YoshidaMasanori ShinoharaHideki NakayamaPublished in: Oral diseases (2020)
The serum amylase level at the beginning of chemoradiotherapy may be a predictor of the recovery of the saliva volume. Furthermore, cytokines such as epidermal growth factor and keratinocyte growth factor in resting saliva affect the development of oral mucositis during chemoradiotherapy.